Digital Health Event Highlights Innovation, Wireless Clinical Trials

Xconomy San Diego — 

Last summer, a team of researchers at San Diego’s Scripps Translational Science Institute (STSI) began a clinical study called “Wired for Health” to assess whether wireless sensors and related technologies could “bend the curve” on health care spending. At the time, institute director Eric Topol said it would be “one of the first robust, cross-industry studies using multiple mobile medical sensors to determine whether we can lower health care costs and resource consumption through wireless health technology.”

The study followed the appointment of Steven Steinhubl as director of a new digital medicine program at Scripps Health, signaling an expansion beyond the institute’s initial focus on genomics and precision medicine. The significance of Scripps’ move into digital health and wireless clinical studies became manifest last month, when former Qualcomm executive Don Jones became the institute’s first “chief digital officer.”

In the 11 years he spent at Qualcomm (NASDAQ: QCOM), Jones led many of the company’s strategic initiatives in wireless health and has been recognized for his expertise in applied wireless technologies, mobile health, and in creating “network effects” in fitness and healthcare products, apps, and therapies.

Now, he brings that experience and expertise to Scripps. In an e-mail to me Sunday, Jones writes that “Scripps Digital Health has published trials recently about the Zio patch from iRhythm (Francis Collins recently blogged about this trial), GE’s VScan, etc. STSI is performing regulatory trials, validation trials, comparative efficacy trials, and Phase 4 trials, all of which involve connected, digital health technology of one kind or another—some to gather data, some to validate the device/technology, some as part of a series of trials to develop a new product which may include digital technology.”

Jones and Topol are set to talk tomorrow evening about their vision for the future of precision medicine and digital health, and how their work fits into a broader revolution in connected health innovation and the “Internet of things” that is taking place throughout San Diego.

The headliners event, organized by Qualcomm Life and CommNexus, the San Diego nonprofit industry group, includes Rick Valencia, who oversees Qualcomm Life; Resmed (NYSE: RMD) COO Robert Douglas; Kevin Patrick, director of the UC San Diego Center for Wireless and Population Health Systems; and Greg Lucier, the former chairman and CEO of Life Technologies, now part of Thermo Fisher Scientific (NYSE: TMO).

“Eleven years is the longest I’ve stayed with one company and it was a great time to be at Qualcomm and to … Next Page »

Single PageCurrently on Page: 1 2

By posting a comment, you agree to our terms and conditions.

One response to “Digital Health Event Highlights Innovation, Wireless Clinical Trials”